7 Analyst Stocks Under $10 With Massive Upside
In the week of August 27, there were seven key analyst calls for stocks to buy that were trading under $10 per share.
All Work
Jon C. Ogg
Fed Chair Yellen Keeps Rate Hike Talk Alive — When Is Another Matter
Federal Reserve Chair Janet Yellen's latest speech continues to point more toward a Federal Open Market Committee (FOMC) rate hike. The real question is when.
Top Analyst Upgrades and Downgrades: American Airlines, Dollar General, Ecolab, Nike, Southern Copper and More
Friday's top analyst calls from Wall Street include American Airlines, Dollar General, Ecolab, Nike and Southern Copper.
Did Durable Goods Just Set the Stage for a Rate Hike?
With the fresh reading on America's durable goods orders coming in quite strong, some watchers are wondering if the odds of a rate hike went up.
How Salesforce.com Shares Could Rise 200% by 2020
Merrill Lynch has reiterated its Buy rating and price objective on Salesforce.com, calling it the firm's favorite large cap growth idea for 2016.
Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More
The top analyst upgrades, downgrades and initiations seen on Thursday morning include DDR, HP, L-3 Communications, Salesforce.com, Teva Pharmaceutical and Twilio.
Meet the New Hemp Derivatives Exchange
The U.S. Commodity Futures Trading Commission has issued an Order of Registration to Seed SEF LLC, a Chicago-based entity that is now a Swap Execution Facility.
Concerns Persist on Mylan EpiPen Price Gouging — or Do They?
Mylan is under fire for price gouging on its EpiPen. There has been some concern that this was a serious mistake by CEO Heather Bresch.
Why Goldman Sachs Expects Garmin to Stumble Against Fitbit and Apple
It is one thing to see an earnings pop one week followed by key analyst downgrades the next week, but this Goldman Sachs downgrade of Garmin may take the cake.
How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again
Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it a priority review of its cancer drug.
Top Analyst Upgrades and Downgrades: Clovis Oncology, Garmin, Lowe’s, NetApp, On Deck, Pioneer Natural, RSP Permian and More
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Clovis Oncology, Garmin, Lowe's, NetApp, On Deck, Pioneer Natural and RSP Permian.
Warren Buffett’s Highest Dividend Yields Outpacing Dow and Other Yields
24/7 Wall St. wanted to see what were the top holdings with the highest dividend yields in Warren Buffett's equity portfolio. It turns out that the highest stock yields absolutely blow away the yields…
Top Analyst Upgrades and Downgrades: BHP Billiton, Deere, Logitech, Medtronic, Square, Sealed Air, Orbital ATK and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include BHP Billiton, Deere, Logitech, Medtronic, Square, Sealed Air and Orbital ATK.
What Each Olympic Medal Costs Each Country Versus GDP
One interesting view for the larger economic snapshot is seeing how much each gold medal and then all Olympic medals would cost based on each nation's GDP.
Should Caterpillar Still Be the Best DJIA Stock of 2016?
It almost seems too good to be true, but Caterpillar is still the best performing of the 30 Dow Jones Industrial Average components so far in 2016.
Top Analyst Upgrades and Downgrades: Garmin, Micron, US Steel, Urban Outfitters, Williams Companies, Hormel and More
The top analyst upgrades, downgrades and initiations seen Monday morning include Garmin, Micron Technology, U.S. Steel, Urban Outfitters, Williams Companies, Hormel Foods.
Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More
The top analyst upgrades, downgrades and initiations seen on Friday morning include AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson and Hormel.
How Much Medivation Can Really Fetch in a Buyout
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Leading Economic Indicators Point Marginally Higher
Thursday's barrage of economic reports included the Conference Board's report on the Leading Economic Index, known more commonly as the Leading Economic Indicators report.
Philly Fed Shows Cracks in Employment Picture
The Federal Reserve Bank of Philadelphia has released its August Manufacturing Business Outlook Survey, showing that growth in the Fed district was rather weak for the manufacturing sector.